Abstract
The objective of this study is to describe aspects of health-related quality of life (HRQOL) in Mexican patients with antineutrophil cytoplasmic-associated vasculitis (AAV). Cross-sectional comparison study includes patients with established AAV and a comparison group with rheumatoid arthritis (RA), chronic kidney disease (CKD), and healthy subjects. Variables considered were: socio-demographic data, comorbidities, laboratory, disease activity, damage, and Physician’s and Patient’s Global Assessment (PhGA and PtGA). The following measurements were done: Pittsburg sleep quality index, Multidimesional Fatigue Inventory (MFI-20), Hospital Anxiety and Depression Scale, Short Form 36 questionnaire (SF-36), and Health Assessment Questionnaire. 60 patients with AAV were included, median age 54 years, and 60% female. Significant differences were found only in the bodily pain domain of the SF-36 (p = 0.01). Aspects of disease relevant for AAV patients were: fatigue and lack of energy; visual abnormalities; neuropathy; renal impairment; arthritis, and sinusitis. Greater total score on MFI-20 (p < 0.001) and worse PtGA (p = 0.01) were associated with worse physical health. Higher PhGA values were associated with worse physical quality of life (p = 0.01). Greater fatigue score (p = 0.002), greater anxiety-depression score (p = 0.005), and worse PtGA (p = 0.01) were associated with worse mental health quality of life. No differences were found in prevalence of sleep impairment, anxiety, depression, or disability between groups. AAV patients experienced more general and physical fatigue (p < 0.0001), and reduced activity (p = 0.01) than healthy subjects, but similar to RA and CKD patients. Vasculitis has negative effects on patients’ physical and mental HRQOL.
Similar content being viewed by others
References
Walsh M, Mukhtyar C, Mahr A et al (2011) Health related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Care Res (Hoboken) 63:1055–1061
Basu N, Jones GT, Fluck N et al (2010) Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology 49:1383–1390
Merkel PA, Aydin SZ, Boers M et al (2014) Current status of outcome measure development in vasculitis. J Rheumatol 41:593–598
Herlyn K, Hellmich B, Seo P, Merkel PA (2010) Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective. Arthritis Care Res (Hoboken) 62:1639–1645
Merkel PA, Aydin SZ, Boers M et al (2011) The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. J Rheumatol 38:1480–1486
McClean A, Morgan MD, Basu N et al (2016) Physical fatigue, fitness, and muscle function in patients with antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Care Res (Hoboken) 68:1332–1339
Brezinova P, Englbrecht M, Lovric S et al (2013) Coping strategies and depressiveness in primary systemic vasculitis—what is their impact on health-related quality of life? Rheumatology 52:1856–1864
Carpenter DM, Thorpe CT, Lewis M et al (2009) Health-related quality of life for patients with vasculitis and their spouses. Arthritis Care Res (Hoboken) 61:259–265
Carpenter DM, Meador AE, Elstad EA et al (2012) The impact of vasculitis on patients’ social participation and friendships. Clin Exp Rheumatol 30:S15-S21
Tomasson G, Boers M, Walsh M et al (2012) Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res (Hoboken) 64:273–279
Trieste L, Palla I, Baldini C et al (2012) Systemic vasculitis: how little we know about their societal and economic burden. Clin Exp Rheumatol 30:S154-S156
Instituto Nacional de Estadística y Geografía (INEGI) (2017) Estadísticas a propósito del Día Mundial de la Justicia Social, Boletín Informativo. http://www.inegi.org.mx. Accessed 17 Feb 2017
Flossmann O (2015) Risks of treatments and long-term outcomes of systemic ANCA-associated vasculitis. Presse Med 44:e251–e257
Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11
Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107
Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid Arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581
Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85:49–61
Basu N, McClean A, Harper L et al (2014) The characterisation and determinants of quality of life in ANCA associated vasculitis. Ann Rheum Dis 73:207–211
Stone JH, Hoffman GS, Merkel PA et al (2001) A disease specific activity index for Wegener’s granulomatosis: Modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44:912–920
Exley AR, Bacon PA, Luqmani RA et al (1997) Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40:371–380
Buysse DJ, Reynolds CF, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213
Mollayeva T, Thurairajah P, Burton K et al (2016) The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis. Sleep Med Rev 25:52–73
Boada-Grau J, Merino-Tejedor E, Gil-Ripoll C et al (2014) Adaptación al español del Inventario Multidimensional de Fatiga al entorno laboral. Univ Psychol 13:15–23
Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 52:69–77
Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370
Ponte C, Sznajd J, O’Neill L, Luqmani R (2014) Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases. Clin Exp Rheumatol 32(sup 85):S118–S125
Maruish ME (2011) User’s Manual for the SF-36v2 Health Survey, 3rd edn. QualityMetric Incorporated, Lincoln
Bruce B, Fries JF (2003) The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30:167–178
González V, Stewart A, Ritter P, Lorig K (1995) Translation and validation of arthritis outcome measures into Spanish. Arthritis Rheum 38:1429–1446
Zúniga MA, Carrillo-Jiménez GT, Fos PJ et al (1999) Evaluación del estado de salud con la Encuesta SF-36: resultados preliminares en México. Salud Publica Mex 41:110–118
López-Alvarenga JC, Vázquez-Velázquez V, Arcila-Martínez D (2002) Accuracy and diagnostic utility of the Hospital Anxiety and Depression Scale (HAD) in a sample of obese Mexican patients. Rev Invest Clin 54:403–409
Escobar-Córdoba F, Eslava-Schmalbach J (2005) Colombian validation of the Pittsburgh Sleep Quality Index. Rev Neurol 40:150–155
Durán-Arenas l, Gallegos-Carrillo K, Salinas-Escudero G et al (2004) Hacia una base normativa Mexicana en la medición de calidad de vida relacionada con la salud, mediante el Formato Corto 36. Salud Publica Mex 46:306–315
Acock AC (2012) A Gentle Introduction to Stata, 3rd edn. Stata Press, Texas
Basu N, McClean A, Harper L et al (2013) Explaining fatigue in ANCA-associated vasculitis. Rheumatology 52:1680–1685
Basu N, McClean A, Harper L et al (2014) Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology 53:953–956
Novakovich E, Grayson PC (2015) What matters for patients with vasculitis? Presse Med 44:e267–e272
Basu N, Murray AD, Jones GT et al (2014) Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study. Rheumatology 53:2080–2087
Carpenter DM, Kadis JA, Devellis RF et al (2011) The effect of medication-related support on the quality of life of patients with vasculitis in relapse and remission. J Rheumatol 38:709–715
Tomasson G (2013) Quality of life and outcome measures in vasculitis. Best Pract Res Clin Rheumatol 27:69–77
van Tuyl LH, Boers M (2012) Patient’s global assessment of disease activity: what are we measuring? Arthritis Rheum 64:2811–2813
Jolly M, Kosinski M, Garris CP, Oglesby AK (2016) Prospective validation of the lupus impact tracker: a patient-completed tool for clinical practice to evaluate the impact of systemic lupus erythematosus. Arthritis Rheumatol 68:1422–1431
Milman N, Boonen A, Tugwell P, Merkel P (2017) Clinicians’ perspective on key domains in ANCA-associated vasculitis: a Delphi exercise. Scand J Rheumatol 46:112–117
Robson JC, Milman N, Tomasson G et al (2015) Exploration, development, and validation of patient-reported outcomes in antineutrophil cytoplasmic antibody–associated vasculitis using the OMERACT process. J Rheumatol 42:2204–2209
Acknowledgements
The authors would like to thank Irazú Contreras Yáñez for her valuable help in the scoring and interpretation of the SF-36 and HAQ-DI scales.
Author information
Authors and Affiliations
Contributions
AHA and NAC designed the study; AHA, AJG, and NAC participated in acquisition of data; AHA, AJG, and NAC analyzed and interpreted data; AHA and NAC drafted the manuscript; AHA, AJG, and NAC revised the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Funding
None.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Electronic supplementary material
Below is the link to the electronic supplementary material.
296_2017_3904_MOESM1_ESM.docx
Online 1. STROBE Statement. Online Resource 2. AAV patients with and without sleep disorder. Online Resource 3. AAV patients with and without depression or anxiety (DOCX 145 KB)
Rights and permissions
About this article
Cite this article
Hinojosa-Azaola, A., Jiménez-González, A. & Alcocer-Castillejos, N. Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis. Rheumatol Int 38, 631–640 (2018). https://doi.org/10.1007/s00296-017-3904-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-017-3904-1